Illustration: Tiffany Herring/Axios
Arlington Capital Partners plans to sell surgical device company Riverpoint Medical to Novanta for a total of $1.5 billion, the companies announced Tuesday.
Why it matters: Strategics remain in the market for PE-backed medical tech companies.
